Hassan Ul Hussain

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Sickle Cell Disease

Top Venues

International journal of surgery (London, England)

Future cardiology

Health science reports

This page only lists publications with an associated author ORCID identifier.

Publications

Sundus A Ghani, Sheeba Burney, Fiza Muzaffar, Laiba Naseem, Hassan Ul Hussain, Syeda T Rehan, Hassan Mumtaz
Lumasiran: a potential therapy for the management of primary hyperoxaluria type 1? An editorial. International journal of surgery (London, England) 109 (2) (2023)
Sundus A Ghani, Sheeba Burney, Fiza Muzaffar, Laiba Naseem, Hassan Ul Hussain, Syeda T Rehan, Hassan Mumtaz
Lumasiran: a potential therapy for the management of primary hyperoxaluria type 1? An editorial. International journal of surgery (London, England) 109 (2) (2023)
Sundus A Ghani, Sheeba Burney, Fiza Muzaffar, Laiba Naseem, Hassan Ul Hussain, Syeda T Rehan, Hassan Mumtaz
Lumasiran: a potential therapy for the management of primary hyperoxaluria type 1? An editorial. International journal of surgery (London, England) 109 (2) (2023)
Syeda Tayyaba Rehan, Laiba Imran, Aqsa Salim, Syed Owais Javed, Laiba Imran, Hassan Ul Hussain, Jawad Ahmed, Farah Yasmin, Md Saiful Islam, Muhammad Sohaib Asghar
Therapeutic and safety outcomes of intracoronary nicardipine in coronary artery disease patients: a systematic review. Future cardiology (2023)
Sundus A Ghani, Sheeba Burney, Fiza Muzaffar, Laiba Naseem, Hassan Ul Hussain, Syeda T Rehan, Hassan Mumtaz
Lumasiran: a potential therapy for the management of primary hyperoxaluria type 1? An editorial. International journal of surgery (London, England) 109 (2) (2023)
Sundus A Ghani, Sheeba Burney, Fiza Muzaffar, Laiba Naseem, Hassan Ul Hussain, Syeda T Rehan, Hassan Mumtaz
Lumasiran: a potential therapy for the management of primary hyperoxaluria type 1? An editorial. International journal of surgery (London, England) 109 (2) (2023)
Syeda Tayyaba Rehan, Hassan Ul Hussain, Farheen Malik, Rana Muhammad Usama, Muhammad Junaid Tahir, Muhammad Sohaib Asghar
Voxelotor versus other therapeutic options for sickle cell disease: Are we still lagging behind in treating the disease? Health science reports 5 (4) (2022)